Assignee
AGENOVIR CORP
US·1 granted patent·16 pending applications·0 citations·filing 2016–2018
Top patents by PatentIndex Score
17 records- 0154US10117911B2Compositions and methods to treat herpes simplex virus infectionsAGENOVIR CORP·Filed 2016·Granted Nov 6, 2018·0 cites·21 claims
- 0254US2019224284A1Compositions and methods to treat herpes simplex virus infectionsAGENOVIR CORP·Filed 2018·Application pending·0 cites
- 0352US2019201501A1Compositions and methods for cell targeted hpv treatmentAGENOVIR CORP·Filed 2018·Application pending·0 cites
- 0447US2017246260A1Modified antiviral nucleaseAGENOVIR CORP·Filed 2016·Application pending·0 cites
- 0545US2016346360A1Compositions and methods for cell targeted hpv treatmentAGENOVIR CORP·Filed 2016·Application pending·0 cites
- 0641US2017246261A1Antiviral treatment with low immunogenicityAGENOVIR CORP·Filed 2017·Application pending·0 cites
- 0738US2017087225A1Compositions and methods for latent viral transcription regulationAGENOVIR CORP·Filed 2016·Application pending·0 cites
- 0837US2016350476A1Antiviral methods and compositionsAGENOVIR CORP·Filed 2016·Application pending·0 cites
- 0936US2017088828A1Compositions and methods for treatment of latent viral infectionsAGENOVIR CORP·Filed 2016·Application pending·0 cites
- 1036US2017096649A1Transgenic nuclease systems and methodsAGENOVIR CORP·Filed 2016·Application pending·0 cites
- 1136US2017088587A1Antiviral fusion proteins and genesAGENOVIR CORP·Filed 2016·Application pending·0 cites
- 1235US2016348074A1Methods and compositions for treating cells for transplantAGENOVIR CORP·Filed 2016·Application pending·0 cites
- 1335US2016346362A1Methods and compositions for treating cytomegalovirus infectionsAGENOVIR CORP·Filed 2016·Application pending·0 cites
- 1435US2017247690A1Oncoviral treatment with nuclease and chemotherapeuticAGENOVIR CORP·Filed 2017·Application pending·0 cites
- 1533US2017087224A1Delivery methods and compositionsAGENOVIR CORP·Filed 2016·Application pending·0 cites
- 1632US2016287678A1Gene delivery methods and compositionsAGENOVIR CORP·Filed 2016·Application pending·0 cites
- 1730US2017247703A1Antiviral nuclease methodsAGENOVIR CORP·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AGENOVIR CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →